Correction to: Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study
نویسندگان
1 Department of Biology, College of Sciences, Shiraz Branch, Islamic Azad University, Shiraz, Iran
2 Department of Biology, College of Sciences, Shiraz Branch, Islamic Azad University, Shiraz, Iran
3 1. Laser Applications in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 2. Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Obstetrics and Gynecology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
doi
50314چکیده
In the article titled “Extracellular Vesicle-Derived Cord Blood Plasma and Photobiomodulation Therapy Down-Regulated Caspase 3, LC3 and Beclin 1 Markers in the PCOS Oocyte: An In Vitro Study,” published in J Lasers Med Sci 2023;14:e23 (doi: 10.34172/jlms.2023.23), there was an error in the Ethical approval section.The ethics approval code was incorrectly reported as: “The Ethics Committee at Shahid Beheshti Medical University in Tehran, Iran, approved the in vitro clinical study (IR.SBMU.MSP.REC.1401.416). Contributors agreed verbally and in writing to contribute to the study. Patients from Erfan Niyaish hospital (Tehran, Iran) donated oocytes for the current study between 2021 and 2022.”The correct ethics approval code is: IR.SBMU.RETECH.REC.1401.223The corrected sentence should read: “The Ethics Committee at Shahid Beheshti Medical University in Tehran, Iran, approved the in vitro clinical study (IR.SBMU.RETECH.REC.1401.223). Contributors agreed verbally and in writing to contribute to the study. Patients from Erfan Niyaish hospital (Tehran, Iran) donated oocytes for the current study between 2021 and 2022.” This correction has now been updated in both the PDF and HTML versions of the article.
